Klingenstein Fields & Co LP

SEC CIK: 0000859872
Latest filing: Aug 5, 2026

SEC filings (opens in a new tab)

LXRX holding history

Lexicon Pharmaceuticals, Inc. in every 13F filed by Klingenstein Fields & Co LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LXRX overview All 13F holders of LXRX Full Q2 2026 holdings

Shares (Q4 2021): 0; Sold out in Q4 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2021

Holdings of LXRX by Klingenstein Fields & Co LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2021	0	$0	0.0%	−10,618−100.0%	Sold out	Holders
Q3 2021	10,618	$51.0K	<0.1%	00.0%	Unchanged	Holders
Q2 2021	10,618	$49.0K	<0.1%	00.0%	Unchanged	Holders
Q1 2021	10,618	$62.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.